Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Amy Cinar"'
Publikováno v:
Pain and Therapy, Vol 8, Iss 2, Pp 271-280 (2019)
Abstract Introduction In clinical trials for knee osteoarthritis (OAK), rescue medication is commonly provided to manage uncontrolled index-knee pain. The impact of treatment on rescue medication utilization provides important information on the robu
Externí odkaz:
https://doaj.org/article/665e81dff4404e31a8dd8f7fd8750728
Autor:
Andrew I. Spitzer, John C. Richmond, Virginia B. Kraus, Andreas Gomoll, Deryk G. Jones, Kim M. Huffman, Charles Peterfy, Amy Cinar, Joelle Lufkin, Scott D. Kelley
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 1, Pp 109-124 (2019)
Abstract Introduction The aim of this work is to assess the safety and efficacy of repeat administration of triamcinolone acetonide extended-release (TA–ER) in patients with symptomatic knee osteoarthritis (OA), including those with advanced radiog
Externí odkaz:
https://doaj.org/article/965478e548394d4eabd761ade14d6f54
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 11 (2019)
Background: Intra-articular corticosteroids are commonly used for pain relief in patients with knee osteoarthritis. Simultaneous intra-articular corticosteroid (CS) knee injections may be beneficial for the ~80–90% of patients who present with, or
Externí odkaz:
https://doaj.org/article/12e2e04c3ef64fb4be3978091639c8ea
Autor:
Peter Hanson, Amy Cinar, Purvi Mehra, Alan Kivitz, Scott Kelley, Louis M. Kwong, Joelle Lufkin
Publikováno v:
Drugs in R&D
Background and Objectives Osteoarthritis (OA) is a major public health burden. While knee and hip joints are most commonly affected, the glenohumoral (shoulder) joint is also frequently involved. We evaluated the pharmacokinetics and safety/tolerabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fade948f0832006c2ad3725024f853ee
http://europepmc.org/articles/PMC8363704
http://europepmc.org/articles/PMC8363704
Publikováno v:
Rheumatology and therapy. 9(2)
Intra-articular (IA) corticosteroids, including triamcinolone acetonide (TA), are a recommended treatment for hip osteoarthritis. We compared the safety and systemic exposure of TA extended-release (TA-ER) versus TA crystalline suspension (TAcs) in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b320d18937a509d5cc93328322ae49d0
https://pubmed.ncbi.nlm.nih.gov/35258839
https://pubmed.ncbi.nlm.nih.gov/35258839
Autor:
Ryan K. Lanier, Deryk G. Jones, Dennis C. Turk, Nathaniel P. Katz, Edgar L. Ross, Scott Kelley, Andrew I. Spitzer, Joelle Lufkin, Philip G. Conaghan, Alan Kivitz, Amy Cinar
Publikováno v:
Pain and therapy. 11(1)
A phase 3 randomized controlled study comparing triamcinolone acetonide extended-release (TA-ER) to conventional TA crystalline suspension (TAcs) reported variable efficacy results. Enrollment criteria may have contributed to this discrepancy, as mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8c6a5cf0a6537deb549de532c2aaa8
https://pubmed.ncbi.nlm.nih.gov/34791634
https://pubmed.ncbi.nlm.nih.gov/34791634
Publikováno v:
Pain and Therapy, Vol 8, Iss 2, Pp 271-280 (2019)
Pain and Therapy
Pain and Therapy
Introduction In clinical trials for knee osteoarthritis (OAK), rescue medication is commonly provided to manage uncontrolled index-knee pain. The impact of treatment on rescue medication utilization provides important information on the robustness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd247c871e83e2d2f38d49fed59ff7fd
https://doi.org/10.1007/s40122-019-0125-1
https://doi.org/10.1007/s40122-019-0125-1
Autor:
Alan Kivitz, Joelle Lufkin, Joseph J. Ruane, Michael J. Langworthy, Scott Kelley, Philip G. Conaghan, Amy Cinar
Publikováno v:
Advances in Therapy
Introduction Osteoarthritis (OA) is common and its prevalence is increased in military service members. In a phase 3 randomized controlled trial (NCT02357459), a single intra-articular injection of an extended-release formulation of triamcinolone ace
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5123ceb70245743063854ba6ee57e6
https://doi.org/10.1007/s12325-019-00944-3
https://doi.org/10.1007/s12325-019-00944-3
Autor:
John C. Richmond, Scott Kelley, Charles Peterfy, Kim M. Huffman, Andrew I. Spitzer, Deryk G. Jones, Virginia B. Kraus, Joelle Lufkin, Amy Cinar, Andreas H. Gomoll
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, Vol 6, Iss 1, Pp 109-124 (2019)
Rheumatology and Therapy, Vol 6, Iss 1, Pp 109-124 (2019)
Introduction The aim of this work is to assess the safety and efficacy of repeat administration of triamcinolone acetonide extended-release (TA–ER) in patients with symptomatic knee osteoarthritis (OA), including those with advanced radiographic se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0d809dd32cc62a09fb0b465f31eef40
http://europepmc.org/articles/PMC6393263
http://europepmc.org/articles/PMC6393263
Autor:
R. Lanier, Joelle Lufkin, Amy Cinar, Alan Kivitz, Scott Kelley, Deryk G. Jones, Edgar L. Ross, Dennis C. Turk, P.G. Conaghan, Andrew I. Spitzer
Publikováno v:
Osteoarthritis and Cartilage. 28:S492-S493
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a1b84d05cd6cfdcd8b55b9f056ffc9
https://doi.org/10.1016/j.joca.2020.02.770
https://doi.org/10.1016/j.joca.2020.02.770